期刊文献+

PELA作为基因载体的研究 被引量:1

Investigation of biodegradable materials as polymeric gene carriers
下载PDF
导出
摘要 目的 研究可生物降解聚合物 PEL A作为控制释放的基因载体。方法 合成聚乳酸 -聚乙二醇二元共聚物(PEL A) ,包裹质粒 p CH110 ,探讨了 PEL A作为基因载体包裹 DNA的各种影响因素 ,这种控制释放体系的体外降解及释放行为以及对其细胞毒性及体外转染效率进行了测定。结果 制备的 PEL A微球平均粒径 1μm~ 3μm,包裹效率为6 2 %。采用包裹了质粒 p CH110的微球对 COS- 1细胞的细胞毒性及转染实验中得出 :PEL A的细胞毒性较小 ,转染效率较高 ,且能持续表达 96 h,缓释效果较明显。结论 可生物降解聚合物材料 PEL Objective To study the biodegradable polymers PELA as gene controlled released coatings for gene transfer. Methods The poly(Dl lactic acid) co poly(ethylene glycol) (PELA) was synthesized and prepared as the coating of plasmid pCH110 in the transfection. All kinds of factors affecting the loading efficiency, cytotoxicity, transfection efficiency and the course of the degradation and release in vitro were discussed. Results The average diameter of microspheres of PELA was 1~3μm. The loading efficiency was 62%. The transfection efficiency of the pCH110 delivery system for COS 1 cells was high and had few cytotoxicity. After transfection, the X gal assay was positive for 96 h. Conclusion The biodegradable polymeric materials PELA as gene carriers possess the potential superiority.
出处 《西部医学》 2004年第1期6-9,共4页 Medical Journal of West China
基金 国家自然科学基金和 973基金 (No:2 0 0 0 4 0 0 9 2 97740 34)
关键词 基因载体 可生物降解聚合物 微球 转染 Gene carrier Biodegradable polymer Microspheres Tansfection
  • 相关文献

参考文献3

二级参考文献16

  • 1王定国,郑华,胡颖嘉,邱书明.降解材料聚乳酸-聚乙二醇生物相容性的研究[J].北京生物医学工程,1995,14(3):173-177. 被引量:5
  • 2Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines. Life Sci, 1997,60(3) : 163-172.
  • 3Okahashi N, Sasakawa C, Yoshikawa M, et al. Molecular characterization of surface protein antigen gene from serotype c Streptococcus mutans, implicated in dental caries. Mol Microbiol, 1989, 3(8) : 673-678.
  • 4Michalek SM, Childers NK. Development and out look for a caries vaccine. Oral Biol Med, 1990,1 ( 1 ) : 37-45.
  • 5Huang Y, Hajishengallis G, Miehalek SM. Construction and charaeterization of a salmonella enterica semva typhimurium clone expressing a salivary adhesion of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect Immun, 2000, 68(3) : 1549-1556.
  • 6Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science, 1994,263(5148) : 802-805.
  • 7Cormack BP, Valdivia R_H, Falkow S. FACS-eptimized mutants of the green fluorescent protein (GFP). C, ene, 1996,173( 1 ) : 33-38.
  • 8Jenkinson HF, Demuth DR. Structure, function and immunogenicity of streptococcal antigen I / Ⅱ polypeptides. Mol Microbiol, 1997,23(3):183-190.
  • 9Jenkinson HF, Lamont RJ. Streptococcal adhesion and colonization.Crit REV Oral Biol Med,1997,8(3):175-200.
  • 10Kelly CG, Todryk S, Kendal HL, et al. T-cell, adhesion, B-cell epitopes of the cell surface Streptococcus mutans protein antigen I / Ⅱ . Infect Immun, 1995,63(9) :3649-3658.

共引文献15

同被引文献27

  • 1陈庆华,瞿文.多肽、蛋白质药物的微球给药系统研究进展[J].国外医学(药学分册),1997,24(3):129-133. 被引量:20
  • 2Lee S,Kim MS,Kim JS,et al.Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique.J Microencapsul,2006,23(7):741-749.
  • 3Zhou SB,Liao XY,Li XH,et al.Poly-DL-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems.J Control Release,2003,86(223):195-205.
  • 4William M.Potential of polymer microencap sulation technology for vaccine innovation.Vaccine,1994,12(1):5-11.
  • 5O'Hagan DJ,Jeffery H,Davis SS.Long-term antibody responses in mice follow ing subcutaneous immunization with ovalbum in entrapped in biodegradable m icroparticles.Vaccine,1993,11(9):965-969.
  • 6Esporza I,Kissel T.Parameters affecting the immunogenicity of microencap sulated tetanus toxoid.Vaccine,1992,10(10):714-720.
  • 7Kim SY,Doh HJ,Ahn JS,et al.Induction of mucosal and systemic immune response by oral immunization with H.pylori lysates encapsulated in poly(DL-lactide-co-glycolide) microparticles.Vaccine,1999,17(6):607-616.
  • 8Tobio M.Improved Immunogenicity of a core-coated tetanus toxoid delivery systems.Vaccine,1999,18(7-8):618-622.
  • 9Kaul G,Amiji M.Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:in vitro and in vivo studies.Pharm Res,2005,22(6):951-961.
  • 10Hilbert AK,Fritzsche U,Kissel T,et al.Biodegradable microspheres containing influenza A vaccine:immune response in mice.Vaccine,1999,17(9-10):1065-1073.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部